PIK3CA and head and neck squamous cell carcinoma: MTX-531 was further evaluated against a heterogeneous panel of PIK3CA-mutant HNSCC PDX models obtained from the National Cancer Institute (NCI) Patient-Derived Models Repository (PDMR).